Upadacitinib
|
|
appearance as argument number 1 |
(diseaseMedicine Upadacitinib RheumatoidArthritis Ingesting) | Medicine.kif 5547-5547 | Upadacitinib 是 對於 Ingesting 的 disease 治癒 RheumatoidArthritis |
(documentation Upadacitinib EnglishLanguage "Upadacitinib, sold under the brand name Rinvoq, is a Janus kinase (JAK) inhibitor medication for the treatment of moderately to severely active RheumatoidArthritis in adults where methotrexate (a drug used to treat active arthritis) did not work well or could not be tolerated. It was developed by the biotech company AbbVie. Common side effects include upper respiratory tract infections (common cold, sinus infections), Nausea, Cough, and Fever.[from Wikipedia]") | Medicine.kif 5539-5546 | |
(sideEffect Upadacitinib Fever) | Medicine.kif 5549-5549 | 發熱 是服用 Upadacitinib 的 side effect |
(sideEffect Upadacitinib Nausea) | Medicine.kif 5548-5548 | Nausea 是服用 Upadacitinib 的 side effect |
(subclass Upadacitinib Medicine) | Medicine.kif 5537-5537 | 子類 Upadacitinib and 醫學 |
appearance as argument number 2 |
(subclass Rinvoq Upadacitinib) | Medicine.kif 5552-5552 | 子類 Rinvoq and Upadacitinib |
(termFormat EnglishLanguage Upadacitinib "upadacitinib") | Medicine.kif 5550-5550 |